Clinical Trial Update: Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating the safety and efficacy of oral BAY85-8501 in patients with non-CF bronchiectasis; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• BAY85-8501

Snippet

Sponsor: Bayer | Conditions: Bronchiectasis | Phase 2 | Status: COMPLETED